glycoconjugates

(redirected from Glycoconjugate)
Also found in: Wikipedia.

gly·co·con·ju·gates

(glī'kō-kon'jū-gātz),
A general class of sugar-containing macromolecules of the body including glycolipids, glycoproteins, and proteoglycans.
Farlex Partner Medical Dictionary © Farlex 2012

gly·co·con·ju·gates

(glī'kō-kon'jŭ-găts)
A general class of sugar-containing macromolecules of the body including glycolipids, glycoproteins, and proteoglycans.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012
References in periodicals archive ?
Revised structures for the capsular polysaccharides from Staphylococcus aureus Types 5 and 8, components of novel glycoconjugate vaccines.
Lectins are employed as an excellent tool for examining glycoconjugate changes in mammalian cells during development, cell differentiation, and maturation.
Membrane-bound or soluble forms of Gals have been described with some different functions: it is well established that glycoconjugate recognitionbyGalsplays keyroles during anoikis resistance, metastatic dissemination, and escape of tumor cells from the immune response (see for review [9, 45]).
The isoprenoid metabolites (digoxin, dolichol, and ubiquinone), glycoconjugate metabolism, free radical metabolism, and the RBC membrane composition were studied.
(45) described the coupling of such a disaccharide to BSA generating the glycoconjugate with the propyl group.
Purification and characterization of the egg jelly macromolecules, sialoglyco-protein and fucose sulfate glycoconjugate, of the sea urchin Hemicentrotus pulcherrimus.
A., Hoechstetter, J., Oettl, M., Bernhardt, G., and Buschauer, A., 2008, "Isoenzyme-specific differences in the degradation of hyaluronic acid by mammalian-type hyaluronidases," Glycoconjugate J., 25, 101-109.
Neu[alfa]3-Gal glycoconjugate expresion determines cell susceptibility to the porcine rubulavirus LPMV.
(26,27) Interestingly, glycoconjugate vaccines consisting of pneumococcal polysaccharide coupled to pneumolysin have been reported to promote broader protective immunity in the setting of production of high avidity antibodies with opsonophagocytic activity than conjugates which use non-pneumococcal carriers.
Protein-polysaccharide glycoconjugate vaccines comprise an integral component of immunization efforts against encapsulated bacteria.